Study of ABT-869 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)
Public ClinicalTrials.gov record NCT00517790. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label, Randomized, Phase 2 Study of Efficacy and Tolerability of ABT-869 in Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the effect of the ABT-869 on the NSCLC subjects.
Study identification
- NCT ID
- NCT00517790
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 140 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2007 (Type not available)
- Primary completion
- Jun 2011 (Actual)
- Completion
- Jun 2012 (Actual)
- Last update posted
- Apr 5, 2013
2007 – 2012
United States locations
- U.S. sites
- 18
- U.S. states
- 12
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site Reference ID/Investigator# 7194 | Fountain Valley | California | 92708 | — |
| Site Reference ID/Investigator# 5617 | Los Angeles | California | 90033 | — |
| Site Reference ID/Investigator# 7934 | Sacramento | California | 95817 | — |
| Site Reference ID/Investigator# 5646 | Aurora | Colorado | 80045-0510 | — |
| Site Reference ID/Investigator# 6627 | Waterbury | Connecticut | 06708 | — |
| Site Reference ID/Investigator# 7868 | Newark | Delaware | 19718 | — |
| Site Reference ID/Investigator# 7616 | Port Saint Lucie | Florida | 34952 | — |
| Site Reference ID/Investigator# 5648 | Chicago | Illinois | 60637 | — |
| Site Reference ID/Investigator# 6739 | Evanston | Illinois | 60201 | — |
| Site Reference ID/Investigator# 8100 | Harvey | Illinois | 60426 | — |
| Site Reference ID/Investigator# 5269 | Indianapolis | Indiana | 46202 | — |
| Site Reference ID/Investigator# 6042 | St Louis | Missouri | 63110 | — |
| Site Reference ID/Investigator# 6680 | East Orange | New Jersey | 07018 | — |
| Site Reference ID/Investigator# 5603 | Voorhees Township | New Jersey | 08043 | — |
| Site Reference ID/Investigator# 5652 | Buffalo | New York | 14263 | — |
| Site Reference ID/Investigator# 6184 | Charlotte | North Carolina | 28211 | — |
| Site Reference ID/Investigator# 6777 | Greensboro | North Carolina | 27403 | — |
| Site Reference ID/Investigator# 5650 | Memphis | Tennessee | 38120 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00517790, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 5, 2013 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00517790 live on ClinicalTrials.gov.